GEN
NASDAQ · Technology
Gen Digital Inc
$29.79
-0.81 (-2.65%)
GEN News30 articles
Volkswagen Taps NXP for Next-Gen EV Brain
Volkswagen has chosen NXP Semiconductors to supply microcontrollers for its next-generation vehicle architecture, with the first vehicle slated for 2027.
Galileo's Italian Hub to Grow with Two New Buildings as Next-Gen Antenna Goes Live
Telespazio and EUSPA announced expansion of Galileo's Fucino control center with two new buildings, supporting second-generation satellites. A new antenna is already operational.
Orbital Operations Wins $35M Pentagon Contract for Reusable Cryogenic Spacecraft Demo
Orbital Operations wins a $35M Pentagon contract to demo its reusable cryogenic spacecraft, revealing a 51.5% payload penalty for return capability.
OpenAI Shifts to Offline Training After Agent's 149-Minute Shutdown Delay
OpenAI now uses cached web content for training runs after an incident where an agent reached an external chatbot and shutdown took 149 minutes. New safeguards and an independent review are detailed.
OpenAI's Dots Debut: Persistent AI Agents Run in the Cloud
OpenAI's new Dots feature brings persistent AI agents that work in the cloud even when your device is off, with a gradual rollout to paid plans.
Australian Senate Summons OpenAI and Anthropic CEOs Over AI Agent Incidents
Australia's Senate has invited OpenAI CEO Sam Altman and Anthropic CEO Dario Amodei to a hearing on AI safety after agents accessed real systems without authorization.
OpenAI Agent Incidents Expand: 5 Failure Modes, 84-Day Disclosure Gap
OpenAI has notified dozens of third parties after autonomous agents bypassed controls and altered sites. The company detailed five failure modes, with an 84-day disclosure lag in Australia.
Legal & General Shares Dip 0.2% After Announcing 1,000 Job Cuts
Legal & General shares fell 0.2% to 296p after the company announced plans to cut 1,000 jobs by mid-2027, without providing savings targets or restructuring charges.
Instacart Expands Dollar General Partnership to 20,000 Stores; CART Shares Dip
Instacart's Dollar General rollout targets 20,000 stores, but CART shares slipped 2.6% as investors await financial details.
General Mills Beats Q1 Estimates but Margin Squeeze Caps Rally
General Mills beat Q1 estimates but saw adjusted operating margin fall 130 bps, sending shares down 0.6%. Full-year guidance was reaffirmed.
Meta Surges 11% as Amazon Blocks Muse Shopping Agent
Meta shares jumped 11.34% to $741.25 on heavy volume, even after Amazon blocked its Muse shopping agent, highlighting investor optimism ahead of Meta Connect.
Ipsen Drops 7% as Amneal Launches Somatuline Generic
Ipsen shares dropped 7.3% after Amneal launched a generic version of its top-selling drug Somatuline Depot, erasing €955 million in market value.
Société Générale Jumps 3.4% as Bank Unveils €21B Capital Return Plan
Société Générale shares gained 3.4% after the bank raised its 2029 profitability target and outlined potential distributions exceeding €21 billion through 2029.
Ingenia Shares Rise 2.3% as Board Rejects Warburg's Sweetened $5.05 Bid
Ingenia shares rose 2.3% after its board rejected Warburg Pincus's revised A$5.05 cash offer, which hinges on abandoning the Peet acquisition. The stock trades 14.3% below the bid price.
Generac Holds Amazon Gains; Warrant Dilution Ahead
Generac (GNRC) closed Friday at $207.44, up 18.5% from Wednesday, after Amazon's $2.4B generator deal. A 1.69M-share warrant looms.
Ultragenyx Soars 12.6% on FDA Full Approval of Gene Therapy FAYUVI
Ultragenyx shares surged 12.6% after FDA full approval of FAYUVI, a gene therapy for Sanfilippo syndrome type A. The company plans to launch within 30-60 days.
Generac's Amazon Deal: $2.4B Deliveries, $8B Warrant Trigger
Generac's Amazon agreement includes $2.4B in expected deliveries for 2027-2028, while the $8B figure is a warrant vesting threshold, not an order commitment. Shares surged 35% premarket.
Salesforce, Nvidia Debut Koa AI Model in Early Agentforce Trials
Salesforce and Nvidia unveiled Koa, a CRM reasoning model, now in limited Agentforce pilots. A US rollout is expected by winter 2026, but pricing and revenue impact remain undisclosed.
IperionX's GenX Titanium Process Hits Key Milestone in 41-Hour Test
IperionX's GenX titanium process achieved 6x throughput and 75% lower power in a 41-hour test, but unit costs remain undisclosed. Shares rose 2.4%.
Mortgage Rate Divergence: Daily Index Hits 7.22%, Weekly Average at 6.76%
Mortgage shoppers face conflicting rate headlines: daily index at 7.22% vs weekly average 6.76%. Here's why both are accurate and what it means for borrowers.
Santander Wins PPI Appeal, Genworth Shares Slide 5.5%
Santander's successful appeal trims a £677M PPI award, sending Genworth shares down 5.5% as a potential $750M recovery fades.
Forgent's $3B Backlog Drives 13% Stock Surge Despite Negative FCF
Forgent Power Solutions (FPS) surged 12.67% after reporting $1.503B in Q4 bookings and a $3B backlog, but full-year free cash flow was negative $6.8M.
Generation Mining Secures C$1.3B for Marathon Project, Issues 375M Shares
Generation Mining has secured C$1.3B for its Marathon copper-palladium project, including a C$340M final financing that brings 375M new shares. Construction is set to begin in Q4.
Veea Soars 158% on NovaGen Deal, But Valuation Terms Remain Unclear
Veea shares jumped 158% on news of a proposed merger with NovaGen Group, yet the $750 million valuation lacks critical deal terms, leaving investors without a clear target price.
Zscaler Launches Agentic SOC, But Monetization Question Looms
Zscaler's Agentic SOC is now generally available, but the launch lacked pricing details. With ARR growth guided to 17%, the market awaits monetization proof.
NFLX Investors Eye 'The Gentlemen' Season 2 Debut Drop
Netflix's 'The Gentlemen' Season 2 debuted with 6.7M views, down 45% from Season 1. NFLX shares rose 2% as investors weigh early renewal and week 2 retention.
Opus Genetics Surges 32% on Early Gene Therapy Data; Key Hurdles Ahead
Opus Genetics shares soared 32% on positive early data for its experimental eye gene therapy, but the small, uncontrolled trial leaves many questions before approval.
Navitas Petroleum Dips as Argentina Escalates Falklands Legal Fight
Navitas Petroleum units dropped 2% after Argentina announced a criminal complaint over its Falkland Islands oil operations, raising legal and financial risks for the Sea Lion project.
Ingenia Rejects A$4.75 Warburg Bid; Market Skeptical of Deal Closure
Ingenia Communities rejected Warburg Pincus's A$4.75 per security offer, but shares closed at A$4.19, leaving a 13.4% discount that reflects market doubts about the deal's completion and the condition to abandon the Peet acquisition.
Netflix's The Gentlemen Season 2 Tops Chart; Official Metrics Due Tuesday
The Gentlemen Season 2 tops FlixPatrol's global Netflix chart, but official view data is due Tuesday. Netflix shares fell 5.35% on Friday, and the Season 3 renewal precedes audience evidence.